A high-level meeting of the Drug Regulatory Authority of Pakistan (DRAP) was held last week under the chairmanship of Special Assistant to the Prime Minister (SAPM) on Industries and Production Haroon Akhtar Khan to discuss a joint project with Russia for local insulin production.
The meeting was attended by Russian government representative Denis Nazarov, Secretary Industries and Production Saif Anjum, and senior DRAP officials. The discussions centred on establishing insulin manufacturing facilities in Pakistan through collaboration with Russia.
SAPM Haroon Akhtar Khan said the proposed venture would mark a “new era” in bilateral ties and reaffirmed the government’s commitment, under Prime Minister Shehbaz Sharif’s leadership, to encourage foreign investment and technology transfer. He explained that insulin manufacturing would be carried out in phases, with bulk production and transfer of technology expected within three years.
He added that the project would open new avenues for business cooperation, enhance access to essential medicines for Pakistanis, and stressed that strict compliance from partner companies would be crucial for its success. – ERMD
